Clinical Effects of Brain Machine Interface in Chronic Stroke Patient

July 30, 2020 updated by: Joon-Ho Shin, National Rehabilitation Center, Seoul, Korea

Determination of Clinical Effects of Brain Machine Interface in Chronic Stroke Patient Without Wrist Extensor Strength

Determination of clinical effects of brain machine interface in chronic stroke patient without wrist extensor strength

Study Overview

Detailed Description

The purpose of this study is to compare RecoveriX with individual EEG calibration and without individual EEG calibration to determine the clinical effect of brain machine interface in chronic stroke patient without wrist extensor strength

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, Korea, Republic of, 142884
        • Recruiting
        • National Rehabilitation Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Hemiplegic patients secondary to first cerebrovascular accidents
  • Weak wrist extension
  • Onset ≥ 6 months
  • Fugl-Meyer Assessment score ≥ 19
  • Cognitively intact enough to understand and follow the instructions from the investigator

Exclusion Criteria:

  • Wrist extensor spasticity above or modified ashworth scale 2
  • Severe upper extremity pain that could interfere with rehabilitation therapy
  • Neurological disorders other than stroke that can cause motor deficits
  • Uncontrolled severe medical conditions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: RecoveriX with individual EEG calibration
RecoveriX applied functional electrical stimulation (FES) according to individual brainwave by individual EEG calibration for 4 weeks
RecoveriX applied FES according to individual brainwave by individual EEG calibration for 5 times a week for 4 weeks
Sham Comparator: RecoveriX without individual EEG calibration
RecoveriX applied FES according to the brainwave of other subjects regardless of the individual brainwave for 4 weeks
RecoveriX applied FES according to the brainwave of other subjects regardless of the individual brainwave for 5 times a week for 4 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fugl-Meyer Assessment - upper extremity
Time Frame: 4 weeks after baseline

Fugl-Meyer Assessment is indicator of the level of impairment of upper extremity, with higher scores indicating lower impairment.

Total scores range from 0 to 66, each item being scored on a 3-point scale (0, cannot perform; 1, partially performs; and 2, fully performs the task).

4 weeks after baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Box and block test
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Box and block test measures unilateral gross manual dexterity. Higher scores indicate better gross manual dexterity.
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Jebsen hand function test
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Jebsen hand function test provides a standardized and objective evaluation of fine and gross motor hand function using simulated activities of daily living. Total score is the sum of time taken for each subtest, which are rounded to the nearest second. Shorter times indicate better performance.
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
9-hole peg test
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
9-hole peg test measures finger dexterity in patients with stroke. Scores are based on the time taken to complete the test activity, recorded in seconds.
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Medical Research Council (MRC) scale of affected upper extremity
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline

The MRC is a standardized set of assessments that measure muscle strength and function.

The MRC scale of muscle strength uses a score of 0 to 5 to grade the power of a particular muscle group in relation to the movement of a single joint.

baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Joint position sense
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Joint position sense is tested by holding the most distal joint of a digit by its sides and moving it slightly up or down. First, demonstrate the test with the patient watching so they understand what is wanted then perform the test with their eyes closed.
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Sensation of limb movement
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
For the ability to sense a sharp object, the best screening test uses a safety pin or other sharp object to lightly prick the face, torso, and 4 limbs; the patient is asked whether the pinprick feels the same on both sides and whether the sensation is dull or sharp.
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
active range of motion (AROM) of wrist flexion/extension
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
active range of motion of wrist flexion and extension
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Modified Ashworth scale
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline

Modified Ashworth scale measures resistance during passive soft-tissue stretching.

Scores range from 0-4, with 5 choices. A score of 1 indicates no resistance, and 5 indicates rigidity.

baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Stroke impact scale
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Stroke impact scale evaluates how stroke has impacted your health and life. Each item is rated in a 5-point Likert scale in terms of the difficulty the patient has experienced in completing each item. Summative scores are generated for each domain, scores range from 0-100.
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
electroencephalography (EEG) effective connectivity
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
EEG effective connectivity describes the causal influences that neural units exert over another.
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Stroke rehabilitation motivation scale
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Stroke rehabilitation motivation scale includes 28 items applicable to stroke rehabilitation, adapted from the Sports Motivation Scale. The response to each item is measured on a scale of 1 to 5. Higher score indicates higher rehabilitation motivation level for all items, except three reverse evaluation items (items #5, #12, and #23), for which a higher score indicates lower motivation level.
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Intrinsic motivation inventory
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
The Intrinsic Motivation Inventory assesses participants' interest/enjoyment, perceived competence, effort, value/usefulness, felt pressure and tension, and perceived choice while performing a given activity, thus yielding six subscale scores. A higher score will indicate more of the concept described in the subscale name.
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Motor evoked potential
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
action potential elicited by noninvasive stimulation of the motor cortex through the scalp
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Joon-Ho Shin, National Rehabilitation Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2020

Primary Completion (Anticipated)

December 1, 2021

Study Completion (Anticipated)

December 31, 2021

Study Registration Dates

First Submitted

June 4, 2020

First Submitted That Met QC Criteria

June 25, 2020

First Posted (Actual)

June 30, 2020

Study Record Updates

Last Update Posted (Actual)

July 31, 2020

Last Update Submitted That Met QC Criteria

July 30, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

3
Subscribe